A pharmacist‐managed dosing algorithm for darbepoetin alfa and iron sucrose in hemodialysis patients: A randomized, controlled trial

The attainment of target hemoglobin levels in hemodialysis patients is low. Several factors play a role, such as hyporesponsiveness to erythropoiesis‐stimulating agents (ESA), but also suboptimal prescribing of ESA and iron. The goal of this study was to investigate if a pharmacist‐managed dosing al...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Oever, Francisca Johanna, Heetman‐Meijer, Carolien F. M., Birnie, Erwin, Vasbinder, Erwin C., Swart, Eleonora L., Schrama, Yvonne C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383089/
https://www.ncbi.nlm.nih.gov/pubmed/32715653
http://dx.doi.org/10.1002/prp2.628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383089/
https://www.ncbi.nlm.nih.gov/pubmed/32715653
http://dx.doi.org/10.1002/prp2.628

Ejemplares similares